Skip to main content

Cancer Profiling Market Progress & Manufacturer Contribution Highlighted until 2028

Cancer profiling has emerged as one of the leading approaches used in identification, prognosis, research analysis and treatment of various cancers. Various approaches such as proteomics, genomics, and metabolomics are being used in cancer profiling. Also, precision medicine treatment is being adopted on a large scale in order to analyze individual genetic profiles and offer personalized treatments. Moreover, cancer is the focus of precision medicine. Moreover, around 631 cancer therapies are in the global oncology research and development pipeline.

Next-generation sequencing in the cancer profiling is helping in identifying multiple tumor mutations. Many cancer centers have already adopted next-gen sequencing-based genetic profiling using target gene capturing. Oncologists across the world are using cancer profiling method along with the rise in adoption of cancer biomarkers for tumor profiling. Moreover, factors including point-of-care diagnostic test, and rising demand for personalized medicine is offering opportunities for leading companies in the cancer profiling market.

As per the research report compiled by Fact.MR, the global cancer profiling market is expected to witness strong growth, registering 17.7% CAGR during the forecast period 2017-2026. By the end of 2026, the global cancer profiling market is estimated to reach US$ 122,129.6 million revenue. Increasing incidences of new cases of cancer are resulting in the rising use of cancer profiling. As per National Cancer Institute, new cancer cases are likely to reach 22 million within next two years. Moreover, increasing adoption of precision medicine treatment is also driving the demand for cancer profiling. Below are the few insights on how the global cancer profiling market will perform in the coming years.

Forecast Highlights on Global Cancer Profiling Market
  • North America is expected to remain dominant in the global cancer profiling market during the forecast period 2017-2026. Changing lifestyle with increasing consumption of alcohol, smoking is leading to the increasing number of people suffering from cancer. Moreover, increasing investment in research and development activities are driving the demand for cancer profiling in the region.
  • Asia Pacific Excluding Japan (APEJ) and Europe are also witnessing significant growth in the cancer profiling. Increasing incidence of lung cancer and prostate cancer in central, eastern, and southern Europe is driving the demand for cancer profiling. Meanwhile, breast cancer is the most diagnosed cancer among women in China and India.
  • Next-generation sequencing is expected to be the highly-preferred technique in cancer profiling market. By the end of 2026, next-generation sequencing is estimated to reach 62,000 million revenue.
  • Pharmaceutical and biotech companies are expected to be the largest users of cancer profiling. Pharmaceutical and biotech companies are estimated to surpass US$ 52,400 million revenue by the end of 2026.
  • Diagnosis is expected to witness significant growth in the global cancer profiling market. By the end of 2026, diagnosis is estimated to surpass US$ 40,000 million in terms of revenue.
The report has also profiled leading players in the global market for cancer profiling, which will remain active through 2026. These include companies such as Roche Holdings, Caris Life Sciences, GenScript, Illumina, Inc. (U.S.), Proteome Sciences PLC, BioTheranostics, NeoGenomics Laboratories, RiboMed Biotechnologies Inc., Genomic Health Inc., Oxford Gene Technology Ltd., and Agendia.

Comments

Popular posts from this blog

Electrosurgery Devices Market: Radiofrequency Electrosurgery Devices will Remain the Top-Selling Product

On the back of rising ageing population, increased instances of surgical procedures and technological innovations, the market for electrosurgical devices is likely to slate lucrative growth triggers in the coming years. Significant spike in surgical procedures pertaining neurology, cardiology, gynecology, and several other general surgeries, electrosurgery devices market is in the cusp of exponential growth. Owing to technological innovations the electrosurgery market in North America has demonstrated growth traction over the years. However, increased healthcare spending towards minimally invasive treatment in Asia-Pacific region is expected to propel the market forward, thus contributing as one of the fastest regional hub in electrosurgery devices market. However, factors such as significant product recalls owing to incompliance with FDA framework remain potential challenges for the growth trajectory. Get sample of this report at https://www.factmr.com/connectus/sample?flag=S...

North America to Maintain its Leader Status for the Dermatology Devices Market

 Increasing geriatric population across the world have propelled the demand for the dermatology devices, which in turn has contributed to the growth of the dermatology devices market. Rising adoption of dermatology devices in parallel to the rapid adoption of technology in the dermatology clinics and hospitals for treating skin disorders have been prominent factors for the growth of dermatology devices market. Spur in the spending capability of consumers have facilitated the access to these devices. Pervasiveness of skin disorders has been rising at the global level, which has created demand for acute treatment devices. Developments in the treatment methodologies such as liposuction devices and laser instruments have been successful in attracting the attention of the consumers. A recent report published by Fact.MR states that the global dermatology devices market is anticipated to surpass the whopping value of US$ 1,000 Mn by 2022. Browse Full Report with TOC 'https://www.factm...

Lithotripsy Devices Market: Non-Invasive ESWL Witnessing Immense Traction

The report offers a crisp overview of the lithotripsy devices market, which includes an introduction to the lithotripsy devices market in tandem with a definition of the target product – lithotripsy devices. A systematic breakdown of the lithotripsy devices market has been offered in this chapter, which implies scope of the research involved. Size of lithotripsy devices market has been studied in terms of volume (tons) and value (MN), and forecast on the lithotripsy devices market has been offered for the period between 2018 and 2026. The lithotripsy devices market is projected to continue its steady growth due to the burgeoning cases of kidney stones, coupled with the surging demand for minimally invasive medical treatments. According to Fact.MR report, the  lithotripsy devices market  is anticipated to accelerate at 4.3% CAGR during 2018-2026 to reach a value of US$ 1,095.2 MN by the end of 2026. In recent past, lithotripsy has become the most pref...